Checks heart health in testicular cancer survivors treated with chemotherapy
Looks for hidden heart disease in adult testicular cancer survivors who had cisplatin chemotherapy.
Plain-language title generated from the registry record
Registry title: Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Key facts
- Where
- Indianapolis, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT05611307, who can take part
Where in United States
- Indiana UniversityIndianapolis, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Indiana University
- Trial code
- NCT05611307
- Record updated
- 30 October 2026
- Original description
Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplantRead full original descriptionShow less
Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant
Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
Inclusion: Patients >18 years of age; Patients will be recruited only if cancer-free at clinical evaluation time; For the cases a confirmed TC diagnosis who received one or more cycles of CBCT-based chemotherapies (CBCT group, Arm 2); For the cases with a confirmed TC diagnosis who received one or more cycles of CBCT-based chemotherapies and underwent BMT for relapsed refractory disease (CBCT \& BMT group, Arm 3); For the comparison cohort, biopsy-proven TC patients who had surgery for or surveillance of their testicular cancer and never received CBCTCBCT or BMT (surgical/surveillance, Arm 1).
Exclusion: Prior known myocardial infarction (MI), atherosclerotic cardiovascular disease (ASCVD); Allergy to iodinated contrast; Antecedent chemotherapy for another primary cancer; Significant renal disease (GFR<40).